EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

VSL#3 Probiotic Upregulates Intestinal Mucosal Alkaline Sphingomyelinase and Reduces Inflammation

I Soo, K L Madsen, Q Tejpar, B C Sydora, R Sherbaniuk, B Cinque, L Di Marzio, M Grazia Cifone, C Desimone, R N Fedorak

Canadian Journal of Gastroenterology · 2008 · 22 (3) · 237-242

DOI: 10.1155/2008/520383 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Canadian Journal of Gastroenterology, 2008. Verfasst von I Soo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, University of Alberta, Edmonton, Canada. Die Arbeit wurde bisher 70-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: CIHR.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Alkaline sphingomyelinase, an enzyme found exclusively in bile and the intestinal brush border, hydrolyzes sphingomyelin into ceramide, sphingosine and sphingosine-1-phosphate, thereby inducing epithelial apoptosis. Reduced levels of alkaline sphingomyelinase have been found in premalignant and malignant intestinal epithelia and in ulcerative colitis tissue. Probiotic bacteria can be a source of sphingomyelinase. OBJECTIVE: To determine the effect of VSL#3 probiotic therapy on mucosal levels of alkaline sphingomyelinase, both in a mouse model of colitis and in patients with ulcerative colitis. METHODS: Interleukin-10 gene-deficient (IL10KO) and wild type control mice were treated with VSL#3 (10 9 colony-forming units per day) for three weeks, after which alkaline sphingomyelinase activity was measured in ileal and colonic tissue. As well, 15 patients with ulcerative colitis were treated with VSL#3 (900 billion bacteria two times per day for five weeks). Alkaline sphingomyelinase activity was measured through biopsies and comparison of ulcerative colitis disease activity index scores obtained before and after treatment. RESULTS: Lowered alkaline sphingomyelinase levels were seen in the colon (P=0.02) and ileum (P=0.04) of IL10KO mice, as compared with controls. Treatment of these mice with VSL#3 resulted in upregulation of mucosal alkaline sphingomyelinase activity in both the colon (P=0.04) and the ileum (P=0.01). VSL#3 treatment of human patients who had ulcerative colitis decreased mean (± SEM) ulcerative colitis disease activity index scores from 5.3±1.8946 to 0.70±0.34 (P=0.02) and increased mucosal alkaline sphingomyelinase activity. CONCLUSION: Mucosal alkaline sphingomyelinase activity is reduced in the intestine of IL10KO mice with colitis and in humans with ulcerative colitis. VSL#3 probiotic therapy upregulates mucosal alkaline sphingomyelinase activity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdultAnimalsColitis, UlcerativeColonDisease Models, AnimalFemaleHumansIleumIntestinal MucosaMaleMiceMice, Inbred BALB CMice, KnockoutMiddle AgedProbioticsSphingomyelin PhosphodiesteraseUp-Regulation

Substanzen

Sphingomyelin Phosphodiesterase

Autor:innen und Institutionen

  • Division of Gastroenterology, University of Alberta, Edmonton, Canada.

Förderung

  • CIHR

Zitieren

APA

Soo, I., Madsen, K. L., Tejpar, Q., Sydora, B. C., Sherbaniuk, R., Cinque, B., Di Marzio, L., Cifone, M. G., Desimone, C., & Fedorak, R. N. (2008). VSL#3 Probiotic Upregulates Intestinal Mucosal Alkaline Sphingomyelinase and Reduces Inflammation. Canadian Journal of Gastroenterology, 22(3), 237-242. https://doi.org/10.1155/2008/520383

Vancouver

Soo I, Madsen KL, Tejpar Q, Sydora BC, Sherbaniuk R, Cinque B, et al. VSL#3 Probiotic Upregulates Intestinal Mucosal Alkaline Sphingomyelinase and Reduces Inflammation. Canadian Journal of Gastroenterology. 2008;22(3):237-242. doi:10.1155/2008/520383

BibTeX
@article{Soo2008,
  author = {Soo, I and Madsen, K L and Tejpar, Q and Sydora, B C and Sherbaniuk, R and Cinque, B and Di Marzio, L and Cifone, M Grazia and Desimone, C and Fedorak, R N},
  title = {VSL#3 Probiotic Upregulates Intestinal Mucosal Alkaline Sphingomyelinase and Reduces Inflammation},
  journal = {Canadian Journal of Gastroenterology},
  year = {2008},
  volume = {22},
  number = {3},
  pages = {237--242},
  doi = {10.1155/2008/520383}
}
Kostenlos starten →